An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum

AIMS: Renin–angiotensin–aldosterone system inhibitors (RAASi) are guideline‐recommended therapy for individuals with cardiorenal disease. They are associated with increased risk of hyperkalaemia, a common and life‐threatening disorder for this population. RAASi‐induced hyperkalaemia often leads to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, James O., Coats, Andrew J.S., Kovesdy, Csaba P., Palmer, Biff F., Piña, Ileana L., Rosano, Giuseppe, Sood, Manish M., Zieroth, Shelley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804940/
https://www.ncbi.nlm.nih.gov/pubmed/35791065
http://dx.doi.org/10.1002/ejhf.2612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804940/
https://www.ncbi.nlm.nih.gov/pubmed/35791065
http://dx.doi.org/10.1002/ejhf.2612

Ejemplares similares